Integration of Graph Neural Network and Neural-ODEs for Tumor Dynamic Prediction
Preprint
Abstract
In anti-cancer drug development, a major scientific challenge is disentangling the complex relationships between high-dimensional genomics data from patient tumor samples, the corresponding tumor's organ of origin, the drug targets associated with given treatments and the resulting treatment response. Furthermore, to realize the aspirations of precision medicine in identifying and adjusting treatments for patients depending on the therapeutic response, there is a need for building tumor dynamic models that can integrate both longitudinal tumor size as well as multimodal, high-content data. In this work, we take a step towards enhancing personalized tumor dynamic predictions by proposing a heterogeneous graph encoder that utilizes a bipartite Graph Convolutional Neural network (GCN) combined with Neural Ordinary Differential Equations (Neural-ODEs). We applied the methodology to a large collection of patient-derived xenograft (PDX) data, spanning a wide variety of treatments (as well as their combinations) on tumors that originated from a number of different organs. We first show that the methodology is able to discover a tumor dynamic model that significantly improves upon an empirical model which is in current use. Additionally, we show that the graph encoder is able to effectively utilize multimodal data to enhance tumor predictions. Our findings indicate that the methodology holds significant promise and offers potential applications in pre-clinical settings.Keywords
All Related Versions
This publication has 10 references indexed in Scilit:
- Explainable deep learning for tumor dynamic modeling and overall survival prediction using Neural-ODEnpj Systems Biology and Applications, 2023
- Predicting cancer drug response using parallel heterogeneous graph convolutional networks with neighborhood interactionsBioinformatics, 2022
- TissueNexus: a database of human tissue functional gene networks built with a large compendium of curated RNA-seq dataNucleic Acids Research, 2021
- Identification of high‐dimensional omics‐derived predictors for tumor growth dynamics using machine learning and pharmacometric modelingCPT: Pharmacometrics & Systems Pharmacology, 2021
- Few-shot learning creates predictive models of drug response that translate from high-throughput screens to individual patientsNature Cancer, 2021
- Toward heterogeneous information fusion: bipartite graph convolutional networks for in silico drug repurposingBioinformatics, 2020
- A Living Biobank of Breast Cancer Organoids Captures Disease HeterogeneityCell, 2018
- DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variantsNucleic Acids Research, 2016
- High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug responseNature Medicine, 2015
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000